Escalon Medical Corp.
ESMC
$0.2937
-$0.0531-15.31%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.47M | 3.22M | 2.78M | 3.47M | 2.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.47M | 3.22M | 2.78M | 3.47M | 2.70M |
| Cost of Revenue | 1.87M | 1.65M | 1.57M | 2.00M | 1.58M |
| Gross Profit | 1.60M | 1.57M | 1.21M | 1.47M | 1.12M |
| SG&A Expenses | 1.16M | 1.16M | 1.10M | 1.16M | 1.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.20M | 2.96M | 2.81M | 3.33M | 2.85M |
| Operating Income | 276.00K | 255.90K | -27.00K | 138.30K | -156.60K |
| Income Before Tax | 271.50K | 246.00K | -32.20K | 134.40K | -162.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 271.50K | 246.00K | -32.20K | 134.40K | -162.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 271.50K | 246.00K | -32.20K | 134.40K | -162.10K |
| EBIT | 276.00K | 255.90K | -27.00K | 138.30K | -156.60K |
| EBITDA | 284.80K | 265.80K | -16.30K | 157.60K | -153.00K |
| EPS Basic | 0.02 | 0.02 | -0.01 | 0.02 | -0.02 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.00 | 0.01 | -0.01 |
| EPS Diluted | 0.02 | 0.02 | -0.01 | 0.02 | -0.02 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.00 | 0.01 | -0.01 |
| Average Basic Shares Outstanding | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M |
| Average Diluted Shares Outstanding | 14.17M | 14.08M | 7.42M | 7.42M | 7.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |